MBX Biosciences, Inc.
MBX
$14.89
$0.9957.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 224.91M | 240.79M | 262.15M | 277.06M | 55.26M |
| Total Receivables | 841.00K | 1.39M | 682.00K | 858.00K | 164.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.97M | 1.48M | 3.65M | 2.41M | 3.13M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 472.00K | 626.00K | 803.00K | 838.00K | 242.00K |
| Total Current Assets | 229.19M | 244.28M | 267.29M | 281.17M | 58.80M |
|
|
|||||
| Total Current Assets | 229.19M | 244.28M | 267.29M | 281.17M | 58.80M |
| Net Property, Plant & Equipment | 2.28M | 1.60M | 1.20M | 1.18M | 1.28M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 51.00K | 50.00K | 50.00K | 50.00K | 2.80M |
| Total Assets | 231.52M | 245.93M | 268.54M | 282.40M | 62.88M |
|
|
|||||
| Total Accounts Payable | 5.76M | 4.25M | 5.34M | 5.00M | 3.22M |
| Total Accrued Expenses | 5.85M | 6.11M | 5.55M | 5.75M | 4.82M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 138.00K | 130.00K | 171.00K | 166.00K | 162.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 11.76M | 10.48M | 11.05M | 10.92M | 8.20M |
|
|
|||||
| Total Current Liabilities | 11.76M | 10.48M | 11.05M | 10.92M | 8.20M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 512.00K | -- | -- | 44.00K | 87.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 15.00K | 23.00K | 42.00K | 68.00K | 125.00K |
| Total Liabilities | 12.28M | 10.50M | 11.09M | 11.03M | 8.41M |
|
|
|||||
| Common Stock & APIC | 400.02M | 396.75M | 394.89M | 393.18M | 5.91M |
| Retained Earnings | -180.80M | -161.39M | -137.51M | -121.92M | -103.78M |
| Treasury Stock & Other | 11.00K | 53.00K | 55.00K | 106.00K | -15.00K |
| Total Common Equity | 219.24M | 235.42M | 257.44M | 271.37M | -97.89M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | 152.36M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 152.36M |
|
|
|||||
| Total Common Equity | 219.24M | 235.42M | 257.44M | 271.37M | -97.89M |
| Total Preferred Equity | -- | -- | -- | -- | 152.36M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 219.24M | 235.42M | 257.44M | 271.37M | 54.47M |
|
|
|||||